DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
CVS logo

CVS Health Corporation Stock Price

NYSE:CVS Community·US$121.1b Market Cap
  • 3 Narratives written by author
  • 10 Comments on narratives written by author
  • 497 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CVS Share Price Performance

US$94.66
21.20 (28.86%)
​
US$114.88
Fair Value
US$94.66
21.20 (28.86%)
17.6% undervalued intrinsic discount
US$114.88
Fair Value
Price US$94.66
AnalystConsensusTarget US$114.88
yiannisz US$104.01
julio US$62.09
Wed, 5 Aug 26
Fair ValueUS$114.88
Share Pricen/a

CVS Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$114.88 17.6% undervalued intrinsic discount

Managed Care Margin Recovery And Healthcare Benefits Will Shape Industry Prospects

1users have liked this narrative
1users have commented on this narrative
208users have followed this narrative
YI
yiannisz's
Fair Value
·
Fair Value US$104.01 9.0% undervalued intrinsic discount

Why CVS’s Valuation Signals Opportunity

13users have liked this narrative
9users have commented on this narrative
111users have followed this narrative
JU
julio's
Fair Value
·
Fair Value US$62.09 52.5% overvalued intrinsic discount

CVS VALUATION

1users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
CVS logo
CVS Health
9.0% undervalued intrinsic discount

Why CVS’s Valuation Signals Opportunity

View narrative
YI
yiannisz
Updated 9 Jan
Read Narrative
CVS logo
CVS Health
52.5% overvalued intrinsic discount

CVS VALUATION

View narrative
JU
julio
Updated 16 Oct 2024
Read Narrative
CVS logo
CVS Health
17.6% undervalued intrinsic discount

Managed Care Margin Recovery And Healthcare Benefits Will Shape Industry Prospects

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 5 Aug
Read Narrative

Trending Discussion

DE
CVS logo

I can't help noticing how "analysts" analyze in depth a "mosquito" with proven track record and on the other hand, completely, gulp without chewing a whole cow = AI ! CVS will hit and pass US$125 in three years as long as the orange beast stays out of meddling with more things that he know nothing about.

0
|
0

Recently Updated Narratives

YI
CVS logo

CVS Health: Rebuilding a Healthcare Giant From the Inside Out

Fair Value: US$104.01 9.0% undervalued intrinsic discount
111 fair values setusers have set this as their fair value
9 commentsusers have commented on this narrative
0 likesusers have liked this narrative
JU
CVS logo

CVS VALUATION

Fair Value: US$62.09 52.5% overvalued intrinsic discount
12 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
CVS logo

CVS: GLP 1 Expansion And Legal Risks Will Shape Future Earnings

Fair Value: US$114.88 17.6% undervalued intrinsic discount
208 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued established dividend payer.

2 Risks
4 Rewards
View Full Analysis

CVS Health Corporation Key Details

US$412.6b

Revenue

US$356.3b

Cost of Revenue

US$56.3b

Gross Profit

US$51.4b

Other Expenses

US$4.9b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
3.82
13.64%
1.19%
76.9%
View Full Analysis

About CVS

Founded
1963
Employees
259500
CEO
J. Joyner
WebsiteView website
www.cvshealth.com

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Recent CVS News & Updates

Seeking Alpha • Sep 10

CVS Health: Buy The Pullback Before Earnings Power Ramps Up

Summary CVS Health trades at a discounted 12x forward P/E versus peers, despite robust business momentum and integrated healthcare assets. Q2 2026 saw 7% YoY revenue growth to $106B and 35% adjusted operating income growth, signaling a turnaround in earnings power. Aetna margin restoration, specialty pharmacy growth, and GLP-1 expansion offset risks from elevated medical costs and regulatory headwinds. I maintain a 'Buy' rating, citing undervaluation, improving fundamentals, and potential for resumed buybacks after leverage normalizes. Read the full article on Seeking Alpha

Recent updates

No updates

CVS Health Corporation Competitors

UNH logo

UnitedHealth Group

Symbol: NYSE:UNH
Market cap: US$340.3b
ABT logo

Abbott Laboratories

Symbol: NYSE:ABT
Market cap: US$176.4b
ISRG logo

Intuitive Surgical

Symbol: NasdaqGS:ISRG
Market cap: US$130.4b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide